ADC Review retweeted
The @OncoZine Brief with Peter Hofland on @ukhealthradio - Dr. Heery MD, medical oncologist with expertise in the translational & clinical development of #immunotherapies & Dr. Verstovsek about the developments in treatment of myeloproliferative neoplasm.
bit.ly/3K9XFzF
ADC Review retweeted
The @OncoZineBrief with Peter Hofland on @ukhealthradio - Dr. Matthias Bucerius, Vice President & General Manager at @merckgroup - Helping its clients in developing & manufacturing a variety of products, including antibody-drug conjugates.
👉🏼 🎧 bit.ly/3TD2Zix
ADC Review retweeted
In this @OncoZine Network article, #Certara expert Dr. Julie Bullock discusses how to prepare for success through Project Optimus, an initiative to reform dose optimization and dose selection paradigm in oncology #drugdevelopment.
Read it here: ow.ly/teUx50LjoEF
ADC Review retweeted
Dhruvajyoti (Dhruv) Roy, PhD @heliogenomics joins the @OncoZine editorial advisory board prn.to/3wguLXs
ADC Review retweeted
Meet Novasep at the 13th World ADC - September 6 -9 -- Booth #54 - adc.expert/NovasepWADCSepSD2…
@World_ADC @Novasep @Oncozine #Oncology @pharmazell #adcc #Cancer #pharma #CDMO
ADC Review retweeted
Lynch Syndrome affects 1/300 people, but only 5% of cases are diagnosed.
Listen how @TridentDMG client @AmbryGenetics is making a difference in cancer prevention and early diagnosis with genetic testing in a new episode of the @OncoZine Brief.
open.spotify.com/episode/5qD…
ADC Review retweeted
Sacituzumab Govitecan Receives European Marketing Authorization for the Treatment of mTNBC in Second Line adcreview.com/news/sacituzum… via @adcreview
ADC Review retweeted
The latest updates about Breast Cancer research in ADC Review | Journal of Antibody-drug Conjugates - adcreview.com
#BreastCancerAwareness #CancerDeMama #CancerResearch #cancercare #adc
ADC Review retweeted
[ASAP] Chemical Site-Specific Conjugation Platform to Improve the Pharmacokinetics and Therapeutic Index of Antibody–Drug Conjugates dlvr.it/S8X37G
ADC Review retweeted
Sterling Pharma Solutions experiences record US growth ow.ly/KG3430jL1pd
ADC Review retweeted
adc.expert/Vic-TrastuzumabDu…
Phase III TULIP® study with [vic-]trastuzumab Duocarmazine (SYD985; @Byondis) meets primary endpoint Biopharmaceuticals), #cancer #oncology #breastcancer #adc #clinicaltrials #research #breastcancer @AACR #antibodydrugconjugate @ASH_hematology @ASCO
ADC Review retweeted
This week in The Onco’Zine Brief: Peter Hofland, Ph.D. talks with Tony Polverino, Ph.D.
In the program, Hofland asks Polverino about his work at Zymeworks.
adc.expert/Zymeworks-2021-Ma…
@AACR @ASCO #ASCO21 #cancerresearch #ADC #drugdevelopment @ZymeworksInc
ADC Review retweeted
Peter DeYoung, CEO, Piramal Global Pharma, shares his thoughts on @PiramalPharma’s acquisition of Hemmo Pharma and what this means to our organization.
#PiramalPharma #HemmoPharma #Pharmaceutical
ADC Review retweeted
From testing toxicity to payload selection, what’s the biggest challenge in developing #antibodydrugconjugates?
Experts discussed their developments in #ADC technology at #AntibodyEng. spr.ly/6012y6oFy
ADC Review retweeted
This session with Sara A. Hurvitz, MD, FACP, is designed to help physicians assess the latest available data on antibody-drug conjugates that target HER2/3 overexpression in breast, gastrointestinal, and lung cancers. Register now: bit.ly/3uJx82l #FutureofOncologyNOW2021
ADC Review retweeted
WuXi Bio steps up its ADC manufacturing game with a new, dedicated subsidiary! Along with WuXi STA, WuXi Biologics of Shanghai, created a new subsidiary which will focus on the production of antibody-drug conjugates! #healthcare #CDMO #China
bit.ly/3hSuxzl
ADC Review retweeted
Small molecule impurities can be a significant challenge when designing control systems during therapeutic manufacture of #antibody drug conjugates. Here’s what you need to know to ensure these impurities are controlled and minimized:
bit.ly/3uhvOCw
#biologics #ADC


























